First-In-Human Study to Evaluate Safety of a New Drug Intended for Treatment of Acute Ischemic Stroke
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study to Evaluate Safety and Tolerability of NoNO-42 in Healthy Adults (NCT05636306) | NoNO Inc. | 2022-11-22 |
Track First-In-Human Study to Evaluate Safety of a New Drug Intended for Treatment of Acute Ischemic Stroke automatically
Every clearance here is in the API, with alerts when new ones post.